MARLIN EQUITY PARTNERS
MARLIN EQUITY PARTNERS is a Series C+, growth-equity and buyout fund in Global writing $10M–$50M checks into Healthcare, software, technology, services and industrial-tech.
- Stages
- Series C+, growth-equity, buyout
- Sectors
- Healthcare, software, technology, services, industrial-tech
- Check size
- $10M–$50M
- Invests in
- Global
- Actively investing
- Yes
- Founded
- 2005
- Assets under management
- $9 billion
- Website
- marlinequity.com
Thesis
They look for companies with revenues between $10 million to $2 billion, strong recurring revenue, and operating in fragmented industries ripe for consolidation. Their strategy emphasizes building scalable growth platforms through organic growth acceleration and strategic M&A. As of March 31, 2023, the firm had $8.7 billion in AUM, with recent fund closings including Marlin Equity V ($2.5 billion) and Marlin Heritage II ($750 million). Typical deal sizes range from $10 million to $50 million. The firm was founded in 2005 and is headquartered in Hermosa Beach, California, with an office in London. Marlin has a history of over 260 acquisitions.
Common questions
Does MARLIN EQUITY PARTNERS invest at the Series C+ stage?
Yes. MARLIN EQUITY PARTNERS lists Series C+, growth-equity and buyout among the stages it invests in.
What check size does MARLIN EQUITY PARTNERS write?
MARLIN EQUITY PARTNERS writes $10M–$50M checks.
Where does MARLIN EQUITY PARTNERS invest?
MARLIN EQUITY PARTNERS invests in Global.